Literature DB >> 22913487

Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases.

Wei Xu1, Jing-Ping Lu, Qi-Zhuang Ye.   

Abstract

Natural-product-derived bengamides possess potent antiproliferative activity and target human methionine aminopeptidases (MetAPs) for their cellular effects. Several derivatives were designed, synthesized, and evaluated as MetAP inhibitors. Here, we present four new X-ray structures of human MetAP1 in complex with the inhibitors. Together with the previous structures of bengamide derivatives with human MetAP2 and tubercular MtMetAP1c, analysis of the interactions of these inhibitors at the active site provides structural basis for further modification of these bengamide inhibitors for improved potency and selectivity as anticancer and antibacterial therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913487      PMCID: PMC3470909          DOI: 10.1021/jm3008695

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  33 in total

1.  Identification of pyridinylpyrimidines as inhibitors of human methionine aminopeptidases.

Authors:  Xiaoyi Hu; Anthony Addlagatta; Brian W Matthews; Jun O Liu
Journal:  Angew Chem Int Ed Engl       Date:  2006-06-02       Impact factor: 15.336

2.  pepM is an essential gene in Salmonella typhimurium.

Authors:  C G Miller; A M Kukral; J L Miller; N R Movva
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

3.  Structural analysis of inhibition of Mycobacterium tuberculosis methionine aminopeptidase by bengamide derivatives.

Authors:  Jing-Ping Lu; Xiu-Hua Yuan; Qi-Zhuang Ye
Journal:  Eur J Med Chem       Date:  2011-11-17       Impact factor: 6.514

4.  Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.

Authors:  Anthony Addlagatta; Brian W Matthews
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

Review 5.  Methionine in and out of proteins: targets for drug design.

Authors:  Mark D Vaughan; Peter B Sampson; John F Honek
Journal:  Curr Med Chem       Date:  2002-02       Impact factor: 4.530

6.  Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by bengamide derivatives.

Authors:  Jing-Ping Lu; Xiu-Hua Yuan; Hai Yuan; Wen-Long Wang; Baojie Wan; Scott G Franzblau; Qi-Zhuang Ye
Journal:  ChemMedChem       Date:  2011-04-04       Impact factor: 3.466

7.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.

Authors:  D Ingber; T Fujita; S Kishimoto; K Sudo; T Kanamaru; H Brem; J Folkman
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

8.  Synthesis and antitumor activity of ester-modified analogues of bengamide B.

Authors:  F R Kinder; R W Versace; K W Bair; J M Bontempo; D Cesarz; S Chen; P Crews; A M Czuchta; C T Jagoe; Y Mou; R Nemzek; P E Phillips; L D Tran; R M Wang; S Weltchek; S Zabludoff
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

9.  Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes.

Authors:  S M Arfin; R L Kendall; L Hall; L H Weaver; A E Stewart; B W Matthews; R A Bradshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Characterization of full length and truncated type I human methionine aminopeptidases expressed from Escherichia coli.

Authors:  Jing-Ya Li; Ling-Ling Chen; Yong-Mei Cui; Qun-Li Luo; Min Gu; Fa-Jun Nan; Qi-Zhuang Ye
Journal:  Biochemistry       Date:  2004-06-22       Impact factor: 3.162

View more
  8 in total

1.  Decoding the Function of Expansion Segments in Ribosomes.

Authors:  Kotaro Fujii; Teodorus Theo Susanto; Saumya Saurabh; Maria Barna
Journal:  Mol Cell       Date:  2018-12-20       Impact factor: 17.970

Review 2.  The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria.

Authors:  Cristina Porras-Alcalá; Federico Moya-Utrera; Miguel García-Castro; Antonio Sánchez-Ruiz; Juan Manuel López-Romero; María Soledad Pino-González; Amelia Díaz-Morilla; Seiya Kitamura; Dennis W Wolan; José Prados; Consolación Melguizo; Iván Cheng-Sánchez; Francisco Sarabia
Journal:  Mar Drugs       Date:  2022-05-31       Impact factor: 6.085

3.  Design, synthesis and cytotoxicity of bengamide analogues and their epimers.

Authors:  Thi Dao Phi; Huong Doan Thi Mai; Van Hieu Tran; Bich Ngan Truong; Tuan Anh Tran; Van Loi Vu; Van Minh Chau; Van Cuong Pham
Journal:  Medchemcomm       Date:  2016-12-21       Impact factor: 3.597

Review 4.  Marine Natural Products from New Caledonia--A Review.

Authors:  Sofia-Eléna Motuhi; Mohamed Mehiri; Claude Elisabeth Payri; Stéphane La Barre; Stéphane Bach
Journal:  Mar Drugs       Date:  2016-03-16       Impact factor: 5.118

Review 5.  The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.

Authors:  Kimberly N White; Karen Tenney; Phillip Crews
Journal:  J Nat Prod       Date:  2017-02-10       Impact factor: 4.050

Review 6.  Marine-derived angiogenesis inhibitors for cancer therapy.

Authors:  Ying-Qing Wang; Ze-Hong Miao
Journal:  Mar Drugs       Date:  2013-03-15       Impact factor: 5.118

Review 7.  Chemistry and biology of bengamides and bengazoles, bioactive natural products from Jaspis sponges.

Authors:  Cristina García-Ruiz; Francisco Sarabia
Journal:  Mar Drugs       Date:  2014-03-18       Impact factor: 5.118

8.  Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study.

Authors:  Beatriz García-Pinel; Cristina Porras-Alcalá; Laura Cabeza; Raul Ortiz; José Prados; Consolación Melguizo; Iván Cheng-Sánchez; Juan Manuel López-Romero; Francisco Sarabia
Journal:  Mar Drugs       Date:  2020-05-02       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.